BSX Filing
4Filing Date: May 11, 2026

BOSTON SCIENTIFIC CORP (BSX) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001225208-26-005110open_in_new
Total Value$0
Trades2
Insiders1

Transaction Details

Morano Susan E
Director·Direct
Grant · Acquire
Common Stock
Shares+1.28K
Price$0.00
Total Value$0
Shares Owned After11.74K
Transaction DateMay 7, 2026
Footnotes ▸

Grant of restricted stock in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of approximately $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant.

Morano Susan E
Director·Direct
Grant · Acquire
Common Stock
Shares+3.80K
Price$0.00
Total Value$0
Shares Owned After10.46K
Transaction DateMay 7, 2026
Footnotes ▸

Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.

Post-Transaction Holdings

Morano Susan E
SecuritySharesChange
Common Stock11.74K+5.08K (76.26%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-07 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BOSTON SCIENTIFIC CORP (BSX) CIK: 0000885725 --- Reporting Owner --- Name: Morano Susan E CIK: 0001983791 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-07 | Code: A (Grant or award) Shares: +3,800 | Price: $0.00 Shares Owned After: 10,463 | Ownership: D (Direct) Footnotes: [F1] Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. [Transaction #2] Security: Common Stock Date: 2026-05-07 | Code: A (Grant or award) Shares: +1,281 | Price: $0.00 Shares Owned After: 11,744 | Ownership: D (Direct) Footnotes: [F2] Grant of restricted stock in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of approximately $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant. --- Footnotes (Complete Index) --- F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. F2: Grant of restricted stock in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of approximately $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant. --- Signature --- /s/ /s/ Susan Thompson, Attorney-in-Fact (2026-05-11)

keid AI analysis is for reference only and does not constitute investment advice.